Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Snaigune Miskinyte

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The Journal of Allergy and Clinical Immunology|June 21, 2023
Successful treatment of JAK1-associated inflammatory diseaseAntoine Fayand, Véronique Hentgen, Céline Posseme, et al.
JCI Insight|June 7, 2019
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosaSu M Lwin, Farhatullah Syed, Wei-Li Di, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The Journal of Allergy and Clinical Immunology|June 21, 2023
Successful treatment of JAK1-associated inflammatory diseaseAntoine Fayand, Véronique Hentgen, Céline Posseme, et al.
JCI Insight|June 7, 2019
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosaSu M Lwin, Farhatullah Syed, Wei-Li Di, et al.
Pageof 2